Group
ClpP protease activator
The data below refer to patients treated with ClpP protease activator as the sole drug class,
excluding any concurrent use of drugs from other groups.
Individual Drugs
Select a drug to view its individual evidence base (drug + SBRT, no other concurrent systemic drugs). Drugs without available data are shown greyed out.
Dordaviprone
No data